Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
Lancet Infect Dis
.
2023 Aug;23(8):881-882.
doi: 10.1016/S1473-3099(23)00187-1.
Epub 2023 Apr 14.
Authors
Anna Stoliaroff-Pepin
1
,
Thomas Harder
2
Affiliations
1
Immunization Unit, Robert Koch Institute, Berlin, Germany. Electronic address:
[email protected]
.
2
Immunization Unit, Robert Koch Institute, Berlin, Germany.
PMID:
37062303
PMCID:
PMC10101758
DOI:
10.1016/S1473-3099(23)00187-1
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Public Health
Substances
COVID-19 Vaccines